Colombian agency recommends allowing cannabis flower exports
The Colombian government might reconsider its ban on medical cannabis flower exports for commercial purposes.
The Colombian government might reconsider its ban on medical cannabis flower exports for commercial purposes.
The United Nations Commission on Narcotic Drugs (CND) on Wednesday accepted a World Health Organization (WHO) recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs.
Expectations that Latin America would become a significant exporter of cannabis for medical and scientific use have not yet materialized, with total export revenue from the continent estimated to be less than $15 million.
Gröbenzell, Germany-based Ever Pharma is recalling all batches of its cannabis flower product CanPharma 20/1 after detecting contamination above acceptable levels, Marijuana Business Daily has learned.
The growing number of medical cannabis brands and products available to patients in Germany indicates that companies wanting to enter and succeed in that market need to think beyond simply offering a consistent supply of products.